Washington Post - Jan 22, 2007 By Amanda Gardner. MONDAY, Jan. 22 (HealthDay News) -- The idea of an Alzheimer's vaccine, which had run into serious roadblocks, may have a new lease on ...
USA Today - Sep 24, 2007 BASEL, Switzerland (AP) — The drugmaker Novartis AG said Monday that the European Commission had approved its Exelon skin patch to treat Alzheimer's disease ...
Pay-Per-View - St. Petersburg Times - ProQuest Archiver - Jul 17, 2007 The Food and Drug Administration has approved a skin patch that offers help with memory and overall functioning for people with mild to moderate Alzheimer's ...
Medical News Today - Medical News Today (press release) - Jul 22, 2007 A patch that delivers Exelon®, an effective Alzheimer's disease medication, through the patient's skin has been recommended for approval in the European ...
Pay-Per-View - Chemistry and Industry - HighBeam Research - Jul 30, 2007 Skin patch treatment for Alzheimer's.(News) ... find Chemistry and Industry articles. A once-daily skin patch for treating Alzheimer's disease will be made ...
Medical News Today - Medical News Today (press release) - Sep 25, 2007 Exelon patch is the first and only transdermal treatment for Alzheimer's disease, ... The skin patch is applied oncedaily to the back, chest or upper arm of ...
$3.50 - Press Telegram - NewsBank - Sep 3, 2007 That's because many medications now come in patch form. ... Also, patches offer a more consistent dose of a drug through the skin "over an extended amount ...
WKYC-TV - Sep 7, 2007 WASHINGTON -- Alzheimer's patients soon may be able to take medication for the condition through a skin patch. The patch's maker, Novartis Pharmaceuticals, ...
Medical News Today - Medical News Today (press release) - Apr 24, 2007 ... the first skin patch in development for the treatment of Alzheimer's disease, ... The patch showed a low level of skin irritation and very good skin ...
